Clinical Trial Update: Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets [Phase 2]

View source ↗

Summary

Phase 2 trial comparing perioperative versus postoperative chemotherapy with bevacizumab for colorectal cancer with liver metastases; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastasis

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Yonsei University | Conditions: Colorectal Cancer, Liver Metastasis | Phase 2 | Status: COMPLETED